• 1. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 2. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 3. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 4. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 5. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Comprehensive Guide to (R)-tert-Butyl (1-(ethylamino)propan-2-yl)carbamate (CAS No. 869901-70-2): Properties, Applications, and Market Insights

(R)-tert-Butyl (1-(ethylamino)propan-2-yl)carbamate (CAS No. 869901-70-2) is a chiral organic compound with significant relevance in pharmaceutical and fine chemical industries. As a carbamate derivative, it serves as a versatile intermediate in the synthesis of bioactive molecules, particularly in the development of enantioselective drugs. The compound's unique stereochemistry, attributed to the (R)-configuration, makes it invaluable for asymmetric synthesis and chiral resolution processes.

The molecular structure of (R)-tert-Butyl (1-(ethylamino)propan-2-yl)carbamate features a tert-butyl carbamate group and an ethylamino side chain, which contribute to its stability and reactivity. With a molecular formula of C10H22N2O2, this compound exhibits moderate solubility in organic solvents like dichloromethane and ethyl acetate, while being sparingly soluble in water. Its chiral purity is critical for applications in drug development, where enantiomeric excess (ee) often exceeds 98% for pharmaceutical-grade material.

Recent advancements in chiral synthesis have increased demand for (R)-tert-Butyl (1-(ethylamino)propan-2-yl)carbamate, particularly in the production of beta-amino alcohol derivatives. These compounds serve as building blocks for various therapeutic agents, including antiviral medications and cardiovascular drugs. The pharmaceutical industry's growing focus on enantiopure drugs has positioned this compound as a valuable intermediate in modern medicinal chemistry.

In synthetic applications, 869901-70-2 demonstrates excellent compatibility with N-protecting group strategies. The tert-butoxycarbonyl (Boc) group provides robust protection for amines during multi-step syntheses, while the ethylamino moiety offers opportunities for further functionalization. This dual functionality makes the compound particularly useful in peptide mimetics development and structure-activity relationship (SAR) studies.

The global market for (R)-tert-Butyl (1-(ethylamino)propan-2-yl)carbamate has shown steady growth, driven by increasing R&D investments in targeted therapies and personalized medicine. Pharmaceutical companies frequently search for reliable suppliers of this chiral intermediate, with purity specifications and certificates of analysis being key purchasing factors. Current market trends indicate growing demand from Asia-Pacific regions, particularly from contract research organizations specializing in chiral technology.

From a regulatory perspective, 869901-70-2 is not classified as hazardous under major chemical inventories. However, proper handling procedures should be followed, including the use of personal protective equipment in laboratory settings. The compound's stability profile allows for standard storage conditions (2-8°C in airtight containers), making it convenient for research and industrial applications alike.

Innovative applications continue to emerge for this compound, particularly in asymmetric catalysis and organocatalysis. Researchers are exploring its potential as a ligand in transition metal-catalyzed reactions and as a scaffold for enzyme inhibitors. These developments align with current scientific interests in green chemistry and atom-economical synthesis, addressing common search queries about sustainable chiral building blocks.

Quality control of (R)-tert-Butyl (1-(ethylamino)propan-2-yl)carbamate typically involves chromatographic techniques such as HPLC and chiral GC analysis. Analytical methods focus on determining enantiomeric purity and detecting potential impurities, which are crucial considerations for researchers comparing suppliers. Recent publications have highlighted improved synthetic routes that enhance yield while maintaining excellent stereoselectivity, addressing frequent questions about optimization of its production.

For researchers investigating chiral auxiliaries or asymmetric synthesis, 869901-70-2 offers numerous advantages. Its well-defined stereochemistry facilitates the construction of complex molecular architectures with precise spatial orientation. The compound's stability under various reaction conditions makes it particularly valuable for multi-step synthetic sequences in medicinal chemistry programs.

Looking ahead, the scientific community anticipates expanded applications of (R)-tert-Butyl (1-(ethylamino)propan-2-yl)carbamate in drug discovery pipelines. Its structural features align with current trends in fragment-based drug design and molecular hybridization strategies. As pharmaceutical companies increasingly prioritize chiral specificity in drug development, demand for high-quality enantiomerically pure intermediates like this compound is expected to rise significantly.

• 255735-88-7(tert-butyl N-(2-aminopropyl)carbamate)
• 152193-01-6(Carbamic acid,N-[2-(propylamino)ethyl]-, 1,1-dimethylethyl ester)
• 146552-71-8(tert-butyl N-[(1S)-2-amino-1-methyl-ethyl]carbamate)
• 333743-54-7((R)-1-N-Boc-Propane-1,2-diamine hydrochloride)
• 100927-10-4(tert-butyl N-[(1R)-2-amino-1-methyl-ethyl]carbamate)
• 454709-85-4
• 381210-89-5(Carbamic acid,[(1S)-1-methyl-2-[(1-methylethyl)amino]ethyl]-, 1,1-dimethylethyl ester (9CI))
• 226575-85-5(Carbamic acid, [(1S)-2-[(2-hydroxyethyl)amino]-1-methylethyl]-, 1,1-)
• 149632-73-5(Tert-Butyl (1-aminopropan-2-yl)carbamate)
• 121103-15-9((S)-1-N-Boc-Propane-1,2-diamine hydrochloride)